Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RONDOIndependent statistical analysis of Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01796548).
- ROPIndependent statistical analysis of Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00634972).
- ROP1Independent statistical analysis of Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RopivacaineIndependent statistical analysis of Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: Complete Statistical AnalysisIndependent statistical analysis of Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients: Complete Statistical AnalysisIndependent statistical analysis of Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ROSA Total Knee Post Market Study EMEA: Complete Statistical AnalysisIndependent statistical analysis of ROSA Total Knee Post Market Study EMEA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04338893).
- ROSALIEIndependent statistical analysis of First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROSEIndependent statistical analysis of A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ROSEIndependent statistical analysis of Reevaluation Of Systemic Early Neuromuscular Blockade: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509078).
- ROSE/RED ROSEIndependent statistical analysis of Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study: primary endpoint results, effect estimate with confidence interval,…
- Rosiglitazone Effect on Mitochondria and Lipoatrophy: Complete Statistical AnalysisIndependent statistical analysis of Rosiglitazone Effect on Mitochondria and Lipoatrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00367744).
- Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROTATEQ Reexamination Study (V260-037): Complete Statistical AnalysisIndependent statistical analysis of ROTATEQ Reexamination Study (V260-037): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01074242).
- Rotator Cuff Pathway: Complete Statistical AnalysisIndependent statistical analysis of Rotator Cuff Pathway: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03717753).
- Rotator Cuff Tears in Hemiplegic Shoulder: Complete Statistical AnalysisIndependent statistical analysis of Rotator Cuff Tears in Hemiplegic Shoulder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00998868).
- ROUTE-T1DIndependent statistical analysis of Research on Optimizing the Use of Technology With Education: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05564481).
- ROXI-VTE IIIndependent statistical analysis of A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- RPIndependent statistical analysis of REAL Parenting Alcohol and Substance Use App: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03932097).
- RPCWIndependent statistical analysis of Prevention of Alcohol-related Sexual Revictimization in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257603).
- RPDIndependent statistical analysis of Reciprocating Medical Devices - a Study of a New Safety Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: Complete Statistical AnalysisIndependent statistical analysis of rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02498067).
- RPNIIndependent statistical analysis of Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears: Complete Statistical AnalysisIndependent statistical analysis of RPS InflammaDry Detector™ to Determine MMP-9 Levels in Tears: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313351).
- RRRIndependent statistical analysis of Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.: primary endpoint…
- RSLV-132Independent statistical analysis of A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03247686).
- RSV OA=ADJ-023Independent statistical analysis of A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant…
- RSV-OA=ADJ-020Independent statistical analysis of A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults: primary endpoint results, effect estimate with confidence…
- RSVHRIndependent statistical analysis of A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery – GUARD: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RTDIndependent statistical analysis of Obtain a Good Blood Glucose Control With the Paradigm Real Time System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RTGIndependent statistical analysis of Room to Grow Evaluation for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226053).
- RTLS for Healthcare Process Validation: Complete Statistical AnalysisIndependent statistical analysis of RTLS for Healthcare Process Validation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04116957).
- rTMSIndependent statistical analysis of rTMS for the Treatment of Chronic Pain in GW1 Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01608321).
- rTMS Bimodal Treatment For Tinnitus: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of rTMS Bimodal Treatment For Tinnitus: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590264).
- rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: Complete Statistical AnalysisIndependent statistical analysis of rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- rTMS to Enhance Cognitive Performance and Promote Resilience: Complete Statistical AnalysisIndependent statistical analysis of rTMS to Enhance Cognitive Performance and Promote Resilience: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04123496).
- rTMS-FPCCIndependent statistical analysis of Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- rTMSECTIndependent statistical analysis of rTMS in Treatment Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080507).
- RTOG 0424Independent statistical analysis of RTOG 0424, evaluating temozolomide and radiation therapy in patients with gliomas, including trial design, time-to-event endpoints, hazard ratios, statistical methods, and interpretation.
- RTOG 0617Independent statistical analysis of RTOG 0617, evaluating radiation therapy dose and cetuximab with chemotherapy in newly diagnosed unresectable stage III non-small cell lung cancer, with emphasis on survival, competing risks, safety, and…
- RTOG 0825Independent statistical analysis of RTOG 0825, a randomized phase 3 trial of temozolomide and radiation therapy with or without bevacizumab in patients with newly diagnosed glioblastoma.
- RTSSIndependent statistical analysis of Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02992119).
- RUBATOIndependent statistical analysis of Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): primary endpoint results, effect…
- Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…